Orcokinin-2(1-12) is an N-terminal fragment of orcokinin-2 used to identify minimal structural features needed for receptor recognition. Its short sequence highlights turns and flexible regions contributing to docking. Researchers employ it in bioassays comparing full-length and truncated analogs. The peptide aids mapping of essential residues within orcokinin-family agonists.
CAT No: O07011
1. Emu oil in combination with other active ingredients for treating skin imperfections
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.